Skip to main content
Clinical Trials/NCT01205815
NCT01205815RecruitingNot Applicable

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Vanderbilt-Ingram Cancer Center1 site in 1 country3,000 target enrollmentStarted: June 3, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
3,000
Locations
1
Primary Endpoint
Molecular changes in patients' melanoma tissue

Study Overview

Brief Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Molecular changes in patients' melanoma tissue

Time Frame: at 120 months

Tissue is collected upon consent or upon receipt of parafin block, primary aim will be met when all tissues are collected and analyzed at conclusion of study. Intent is to aid patients and their treating physician when making treatment decisions.

Secondary Outcomes

  • Improve the time between ordering the test and results entry into medical records(120 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Douglas Johnson

Associate Professor of Medicine

Vanderbilt-Ingram Cancer Center

Study Sites (1)

Loading locations...

Similar Trials

Storage and Research Use of Human... | Clinical Trial